Glucagon-Like Peptide-1 Receptor Agonists and Fragility Fracture Risk in Type 2 Diabetes.

PubMed 1970-01-01 added 2026-07-24

Hamad CD, Wiener J, Golzar A, Kaur H, Henein C, Kittredge AP, Su G, Kaelber DC, Chan L, Yeaman MR, Adams JS, Bernthal NM, Sheppard WL